FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of formula I .
EFFECT: new compounds of formula I are obtained which are inhibitors of the ROMK channel and which can be used in hypertension treatment.
11 cl, 5 tbl, 85 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M | 2019 |
|
RU2817018C2 |
NOVEL PIPERIDINE DERIVATIVES | 2006 |
|
RU2417985C2 |
BICYCLIC HETEROCYCLIC SPIROCOMPOUNDS | 2010 |
|
RU2506266C2 |
OXASPIRO DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINES | 2016 |
|
RU2733373C2 |
AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS | 2015 |
|
RU2683309C2 |
DERIVATIVE OF PYRIMIDINE AND A FIVE-MEMBERED NITROGEN-CONTAINING HETEROCYCLE, METHOD FOR PRODUCTION AND MEDICAL APPLICATIONS THEREOF | 2019 |
|
RU2775229C1 |
SPIROAZACYCLIC COMPOUNDS, METHOD FOR INHIBITION IF ACTIVITY OR ACTIVATION OF SEROTONIN 5-НТ2А RECEPTOR, METHOD FOR TREATMENT OF MORBID STATE ASSOCIATED WITH SEROTONIN 5-НТ2А RECEPTOR AND THEIR USING | 2002 |
|
RU2315051C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
Authors
Dates
2018-01-24—Published
2013-07-25—Filed